Azenta, Inc. AZTA 深 沪
等待开盘 08-20 09:30:00 美东时间
35.62
+2.640
+8.00%
华盛通- 最 高35.89
- 今 开33.72
- 成交量 83.99万股
- 最 低 33.72
- 昨 收 32.98
- 总市值 15.60亿
- 52周最高 41.73
- 市盈率 静 --
- 换手率 1.92%
- 52周最低 15.93
- 委 比 -71.17%
- 总股本 4380.84万
- 历史最高 124.69
- 量 比 1.64
- 振 幅 6.58%
- 历史最低 3.92
- 每 手 1
- 风险率 5.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | Azenta, Inc. 2026财年Q2营收1.61亿美元，同比增长12.0%；归母净利润0.02亿美元，扭亏为盈
华盛资讯8月7日讯，Azenta, Inc.公布2026财年Q2业绩，公司Q2营收1.61亿美元，同比增长12.0%，归母净利润0.02亿美元，扭亏为盈。
08-07 11:19
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
Needham Maintains Buy on Azenta, Raises Price Target to $37
Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and raises the price target from $33 to $37.
08-06 01:57
财报速睇 | Azenta, Inc. 2026财年Q2营收1.61亿美元，同比增长12.0%；归母净利润0.02亿美元，扭亏为盈
华盛资讯8月5日讯，Azenta, Inc.公布2026财年Q2业绩，公司Q2营收1.61亿美元，同比增长12.0%，归母净利润0.02亿美元，扭亏为盈。
08-05 05:48
Azenta Narrows FY2026 Sales Guidance from $603.000M-$621.000M to $613.000M-$618.000M vs $600.458M Est
Azenta (NASDAQ:AZTA) narrows FY2026 sales outlook from $603.000 million-$621.000 million to $613.000 million-$618.000 million vs $600.458 million estimate.
08-05 04:31
Azenta Q3 Adj. EPS $0.16 Beats $0.11 Estimate, Sales $161.000M Beat $149.288M Estimate
Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.11 by 45.45 percent. This is a 15.79 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $161.000 million which be...
08-05 04:31
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
BURLINGTON, Mass., May 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating co...
05-22 04:05
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Needham Maintains Buy on Azenta, Lowers Price Target to $33
Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $44 to $33.
05-07 04:08
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wedn...
05-07 01:05
